Literature DB >> 2564577

Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole.

D Goldfain, M F le Bodic, A Lavergne, A Galian, R Modigliani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564577     DOI： 10.1016/s0140-6736(89)92590-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

Review 2.  Use of omeprazole in patients with Zollinger-Ellison syndrome.

Authors:  H Frucht; P N Maton; R T Jensen
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 3.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 4.  Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.

Authors:  D C Metz; J R Pisegna; V A Fishbeyn; R V Benya; R T Jensen
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

Review 5.  Hyperplastic proliferations of the ECL cells.

Authors:  Y Dayal
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec

Review 6.  Clinical aspects of ECL-cell abnormalities.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1998 May-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.